Could a Once-Daily inhaler replace four daily doses for COPD attacks?
NCT ID NCT07721922
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial compares two long-acting bronchodilators (formoterol and revefenacin) against the standard short-acting combination (albuterol and ipratropium) for people hospitalized with a COPD flare-up. The goal is to see whether the longer-acting drugs can relieve shortness of breath just as well with fewer daily doses. About 280 adults aged 40 and older with COPD will take part, and their breathing difficulty will be tracked using a standard scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a combination of two long-acting bronchodilators: formoterol and revefenacin
- What this could lead to
- If it works, this could simplify treatment for COPD flare-ups by requiring fewer doses per day while providing similar symptom relief.
- What could go wrong
- This is a phase 4 trial testing a non-inferiority hypothesis, so even if the new regimen matches standard care, it may not offer a clear advantage. The study is also limited to hospitalized patients, so results may not apply to milder cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sensing your body's signals ease COPD symptoms?
- Routine blood test may reveal hidden clues in COPD emergencies
- Could a simple nasal device replace ventilators for COPD emergencies?
- Can a simple blood test guide steroid use in COPD emergencies?
- Scientists expose COPD patients to ozone to uncover Pollution's hidden impact
- New clinic aims to cut COPD Flare-Ups in half